New eye implant offers hope for glaucoma patients failing drops

NCT ID NCT07235592

First seen Nov 19, 2025 · Last updated May 12, 2026 · Updated 21 times

Summary

This study tests a small device called the PRESERFLO MicroShunt XI in 112 adults with primary open-angle glaucoma whose eye pressure remains high despite using maximum eye drops. The implant is designed to drain fluid and lower pressure, helping to control the disease and prevent vision loss. Participants will be followed for 12 months to see if the device safely reduces eye pressure by at least 20%.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN-ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AKH Wien

    Vienna, Austria

    Contact

  • Glaucoma Clinic, UZ Leuven

    Leuven, Belgium

    Contact

  • Guy's and St. Thomas' NHS Foundation Trust

    London, United Kingdom

    Contact

  • Hospital Clinico San Carlos

    San Carlos, Spain

    Contact

  • Internationale Innovative Opthalmochirurgie GbR

    Düsseldorf, Germany

    Contact

  • Irccs Fondazione G. B. Bietti

    Rome, Italy

    Contact

  • Moorfields Eye Hospital NHS Foundation Trust

    London, United Kingdom

    Contact

  • Policlinico Universitario Molinette

    Turin, Italy

    Contact

  • ULS Santa Maria, Lisboa

    Lisbon, Portugal

    Contact

  • Universiteitskliniek voor Oogheelkunde Maastricht

    Maastricht, Netherlands

    Contact

  • Universitätsklinikum Tübingen, Department für Augenheilkunde

    Tübingen, Germany

    Contact

Conditions

Explore the condition pages connected to this study.